HSBC Holdings
FLGT icon

HSBC Holdings’s Fulgent Genetics FLGT Stock Holding History

HSBC Holdings’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,800
Closed -$255K – 3288
2021
Q3 		$255K Buy
+2,800
New +$254K ﹤0.01% 2637

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

HSBC Holdings's FLGT Position: Q1 2026 in Review

HSBC Holdings increased its Fulgent Genetics (FLGT) stake by 25% in Q1 2026, buying an estimated $285K and bringing the position to 65,174 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #1847.

HSBC Holdings first reported a position in FLGT in Q1 2021 and has held it in 17 quarters since. The position peaked at $1.79M in Q1 2021. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • HSBC Holdings held 65,174 shares of Fulgent Genetics worth $1.03M as of Q1 2026.
  • HSBC Holdings bought 13,118 Fulgent Genetics shares in Q1 2026, an estimated $285K.
  • Fulgent Genetics made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #1847 holding.
  • HSBC Holdings first reported a position in Fulgent Genetics in Q1 2021 and has held it in 17 quarters since.
  • HSBC Holdings's Fulgent Genetics position peaked at $1.79M in Q1 2021.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.